Loading…
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
Pantel, Austin R., Gitto, Sarah B., Makvandi, Mehran, Kim, Hyoung, Medvedv, Sergey, Weeks, Joanna K., Torigian, Drew A., Hsieh, Chia-Ju, Ferman, Benjamin, Latif, Nawar A., Tanyi, Janos L., Martin, Lainie P., Lanzo, Shannon M., Liu, Fang, Cao, Quy, Mills, Gordon B., Doot, Robert K., Mankoff, David A., Mach, Robert H., Lin, Lilie L., Simpkins, Fiona
Published in Clinical cancer research (14.04.2023)
Published in Clinical cancer research (14.04.2023)
Get full text
Journal Article
Loading…
A PARP1 PROTAC as a novel strategy against PARP inhibitor resistance via promotion of ferroptosis in p53-positive breast cancer
Li, Ge, Lin, Shan-shan, Yu, Ze-lei, Wu, Xin-hua, Liu, Jing-wen, Tu, Gui-hui, Liu, Quan-yu, Tang, Yuan-ling, Jiang, Qing-na, Xu, Jian-hua, Huang, Qing-ling, Wu, Li-xian
Published in Biochemical pharmacology (01.12.2022)
Published in Biochemical pharmacology (01.12.2022)
Get full text
Journal Article
Loading…
Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study
Park, Junsik, Kim, Se Ik, Jeong, Soo Young, Kim, Yup, Bookman, Michael A., Kim, Jae-Weon, Kim, Byoung-Gie, Lee, Jung-Yun
Published in Gynecologic oncology (01.04.2022)
Published in Gynecologic oncology (01.04.2022)
Get full text
Journal Article
Loading…
PARP Inhibitors in Ovarian Cancer
Mittica, Gloria, Ghisoni, Eleonora, Giannone, Gaia, Genta, Sofia, Aglietta, Massimo, Sapino, Anna, Valabrega, Giorgio
Published in Recent patents on anti-cancer drug discovery (01.01.2018)
Published in Recent patents on anti-cancer drug discovery (01.01.2018)
Get more information
Journal Article
Loading…
An Analysis of Patients with DNA Repair Pathway Mutations Treated with a PARP Inhibitor
Borazanci, Erkut, Korn, Ronald, Liang, Winnie S., Guarnieri, Carol, Haag, Susan, Snyder, Courtney, Hendrickson, Kristin, Caldwell, Lana, Von Hoff, Dan, Jameson, Gayle
Published in The oncologist (Dayton, Ohio) (01.01.2020)
Published in The oncologist (Dayton, Ohio) (01.01.2020)
Get full text
Journal Article
Loading…
Loading…
Loading…
Maintenance with niraparib in patients with stage III, stage IV, chemo-naïve recurrent or platinum-sensitive recurrent uterine serous carcinoma: study protocol for a phase II clinical trial
Frimer, Marina, Katcher, Arielle, Blustein, Pegah, Sison, Cristina, Girda, Eugenia, Nizam, Aaron, Tymon-Rosario, Joan, Goldberg, Gary L, Menzin, Andrew, Valea, Fidel, Scanlon, Lauren, Whyte, Jill S, Sakaris, Antoinette, Pereira, Elena, Villella, Jeannine, Kuo, Yi-shin D, Lee, Jean, Siebel, Marisa, Danziger, Natalie, Elvin, Julia, Shih, Karin, dos Santos, Lisa, John, Veena
Published in BMJ open (05.06.2025)
Published in BMJ open (05.06.2025)
Get full text
Journal Article
Loading…
A Population Pharmacokinetic Meta‐Analysis of Veliparib, a PARP Inhibitor, Across Phase 1/2/3 Trials in Cancer Patients
Stodtmann, Sven, Nuthalapati, Silpa, Eckert, Doerthe, Kasichayanula, Sreeneeranj, Joshi, Rujuta, Bach, Bruce A., Mensing, Sven, Menon, Rajeev, Xiong, Hao
Published in Journal of clinical pharmacology (01.09.2021)
Published in Journal of clinical pharmacology (01.09.2021)
Get full text
Journal Article
Loading…
Loading…
The efficacy and adverse effects of PARP inhibitor combined with chemotherapy compared with chemotherapy alone in the treatment of cancer patient: A protocol for systematic review
Zhao, Suyue, Fang, Tao, Yao, Li, Zheng, Ying, Zhang, Ling, Zhu, Kexiang
Published in Medicine (Baltimore) (06.11.2020)
Published in Medicine (Baltimore) (06.11.2020)
Get full text
Journal Article
Loading…
Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance
Wang, Ling, Wang, Qi, Xu, Yangchun, Cui, Manhua, Han, Liying
Published in Current drug targets (01.01.2020)
Published in Current drug targets (01.01.2020)
Get more information
Journal Article
Loading…
Knowledge and attitude of hereditary breast cancer among Japanese university female students
Terui-Kohbata, Hiroko, Egawa, Makiko, Yura, Kei, Yoshida, Masayuki
Published in Journal of human genetics (01.07.2020)
Published in Journal of human genetics (01.07.2020)
Get full text
Journal Article
Loading…
Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults
Watanabe, Tomoko, Honda, Takayuki, Totsuka, Hirohiko, Yoshida, Masayuki, Tanioka, Maki, Shiraishi, Kouya, Shimada, Yoko, Arai, Eri, Ushiama, Mineko, Tamura, Kenji, Yoshida, Teruhiko, Kanai, Yae, Kohno, Takashi
Published in Breast cancer research and treatment (01.07.2020)
Published in Breast cancer research and treatment (01.07.2020)
Get full text
Journal Article
Loading…
Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer
Kim, Hyun-Ki, Lee, Eun Jin, Lee, Young-Jae, Kim, Jisun, Kim, Yongsub, Kim, Kyunggon, Lee, Shin-Wha, Chang, Suhwan, Lee, Young Joo, Lee, Jong Won, Lee, Woochang, Chun, Sail, Son, Byung Ho, Jung, Kyung Hae, Kim, Yong-Man, Min, Won-Ki, Ahn, Sei-Hyun
Published in Journal of human genetics (01.03.2020)
Published in Journal of human genetics (01.03.2020)
Get full text
Journal Article
Loading…